carboplatin,durvalumab,paclitaxel,olaparib,bevacizumab
astrazeneca,merck,roche
['duo-o', 'ovarian', 'brca']
today at 17:12 gmt-5, duo-o trial abstract will be presented at #asco23 want to learn more? stay tuned for dr mirza's take on the data and what they will mean for patients with newly diagnosed advanced #ovariancancer (non-tbrcam). available just next week! #meded #oncology 
COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally. #COR2ED #MedEd #IME